| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/24/2011 | WO2011035120A2 Therapeutic composition to treat lesions caused by herpes simplex virus |
| 03/24/2011 | WO2011035018A2 Suicide ready cells |
| 03/24/2011 | WO2011034953A2 Lassa virus-like particles and methods of production thereof |
| 03/24/2011 | WO2011034582A2 Hiv-1 antibodies |
| 03/24/2011 | WO2011034528A1 Cold and flu symptomatic relief composition |
| 03/24/2011 | WO2011034518A1 Hcv protease inhibitors |
| 03/24/2011 | WO2011034462A1 Combined anti-tuberculosis preparation |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034181A1 Gene expressing a bifidobacterium surface-presented fusion protein |
| 03/24/2011 | WO2011034039A1 Eradicating agent and eradication method for helicobacter pylori |
| 03/24/2011 | WO2011033319A1 Commensal neisserial stress protein preparations |
| 03/24/2011 | WO2011033310A1 Encapsulated intestinal flora extracted from feces for use in the treatment of gastrointestinal disorders |
| 03/24/2011 | WO2011033275A1 Bacterial spore having therapeutic agent adsorbed on its surface |
| 03/24/2011 | WO2011033045A1 Heterocyclic antiviral compounds |
| 03/24/2011 | WO2011032489A1 Method of using poxvirus vector hiv vaccine combined with adenoviral vector hiv vaccine and the uses thereof |
| 03/24/2011 | WO2011032203A1 Contact lens disinfecting solutions |
| 03/24/2011 | WO2011032192A1 Substituted clavulanic acid |
| 03/24/2011 | WO2010149980A3 Topical formulation containing a tetracycline and a method of treating skin infections using the same |
| 03/24/2011 | WO2010131865A3 Antimicrobial composition with an activity against an antibiotic-resistant strain |
| 03/24/2011 | WO2010129048A3 Therapeutic compounds |
| 03/24/2011 | WO2010111653A3 Modulating ires-mediated translation |
| 03/24/2011 | WO2010111586A3 Mucosal immunization |
| 03/24/2011 | WO2010111516A3 Compositions and methods for inhibiting biofilms |
| 03/24/2011 | WO2010014134A8 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/24/2011 | WO2008116468A8 Mhc peptide complexes and uses thereof in infectious diseases |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071210 Methods and compositions for the treatment of cancer or other diseases |
| 03/24/2011 | US20110071208 Lipid encapsulated dicer-substrate interfering rna |
| 03/24/2011 | US20110071202 Anti-hepatitis c virus agents and anti-hiv agents |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071158 New compounds |
| 03/24/2011 | US20110071155 Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071116 Antimicrobial n-halogenated amino acid salts |
| 03/24/2011 | US20110071115 Pharmaceutically useful heterocycle-substituted lactams |
| 03/24/2011 | US20110071114 Compositions and methods for treating bacterial infections using ceftaroline |
| 03/24/2011 | US20110071108 Beta-Cyclodextrin Derivatives as Antibacterial Agents |
| 03/24/2011 | US20110071096 Macrolides Having Antibiotic Activity |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071091 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/24/2011 | US20110071077 Thrombopoietic Compounds |
| 03/24/2011 | US20110071072 Antifungal Bone Cements |
| 03/24/2011 | US20110070651 Recombinant viral vector for gene transfer into lymphoid cells |
| 03/24/2011 | US20110070321 Method and Composition for Cutaneous Treatment of Herpes Simplex Infections |
| 03/24/2011 | US20110070316 Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070296 Topical compositions and methods for utilizing peptides containing lipid-modified cysteine-containing peptides |
| 03/24/2011 | US20110070284 Biologic matrices comprising anti-infective methods and compositions related thereto |
| 03/24/2011 | US20110070266 Immunogenic compositions for chlamydia trachomatis |
| 03/24/2011 | US20110070265 Engineered pertactin variants for vaccine use |
| 03/24/2011 | US20110070264 Rabies virus vector systems and compositions and methods thereof |
| 03/24/2011 | US20110070262 Viral Vectors and Their Use in Therapeutic Methods |
| 03/24/2011 | US20110070261 Combination Vaccines Against Mycobacterium SP. and Methods of Using the Same |
| 03/24/2011 | US20110070260 Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| 03/24/2011 | US20110070259 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 03/24/2011 | US20110070257 Polyvalent Chimeric OSPC Vaccinogen and Diagnostic Antigen |
| 03/24/2011 | US20110070256 Vaccine Antigens from Piscirickettsia Salmonis |
| 03/24/2011 | US20110070254 Mutations in the influenza a virus ns1 gene and use thereof |
| 03/24/2011 | US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof |
| 03/24/2011 | US20110070235 Compositions and methods for the therapy and diagnosis of influenza |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | US20110070217 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 03/24/2011 | US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
| 03/24/2011 | US20110070198 Plant-based biocidal materials and systems |
| 03/24/2011 | US20110070197 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070196 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070195 Uses of spatial configuration to modulate protein function |
| 03/24/2011 | US20110070194 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 03/24/2011 | US20110070193 Anti-Infective Agents and Uses Thereof |
| 03/24/2011 | US20110070192 Method of preparation of novel nucleoside analogs and uses |
| 03/24/2011 | US20110070191 T cell receptor fusions and conjugates and methods of use there of |
| 03/24/2011 | US20110070190 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070189 Heterocyclic antiviral compounds |
| 03/24/2011 | US20110070187 Methods for the Preparation of HCV Polymerase Inhibitors |
| 03/24/2011 | US20110070168 Macrocyclic peptides as inhibitors of viral replication |
| 03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
| 03/24/2011 | DE102009029630A1 Antimikrobielle Amide Antimicrobial amides |
| 03/24/2011 | CA2774796A1 Contact lens disinfecting solutions |
| 03/24/2011 | CA2774772A1 Compositions and methods for treating bacterial infections using ceftaroline |
| 03/24/2011 | CA2774475A1 Lassa virus-like particles and methods of production thereof |
| 03/24/2011 | CA2774446A1 Hiv-1 antibodies |
| 03/24/2011 | CA2774145A1 Hcv protease inhibitors |
| 03/24/2011 | CA2773999A1 Gene expressing a bifidobacterium surface-presented fusion protein |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2768924A1 Heterocyclic antiviral compounds |
| 03/23/2011 | EP2298934A1 S. pneumoniae antigens |
| 03/23/2011 | EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 03/23/2011 | EP2298900A1 Compositions and methods for treating intracellular diseases |
| 03/23/2011 | EP2298804A2 Monoclonal antibody production by EBV transformation of B cells |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298796A2 Staphylococcus aureus proteins and nucleic acids |